Cingulate (CINGW) EBITDA (2021 - 2026)

Cingulate (CINGW) has reported EBITDA for 6 consecutive years, with -$5.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 16.45% year-over-year to -$5.4 million; the trailing twelve-month figure through Jun 2026 stood at -$21.6 million (down 21.3% YoY), and the FY2025 full-year result was -$19.9 million, down 27.44% from the prior year.
• EBITDA improved to -$5.4 million in Q2 2026 per CINGW's latest filing, from -$5.6 million in the prior quarter.
• Across five years, EBITDA topped out at -$2.9 million in Q1 2024 and bottomed at -$6.8 million in Q4 2023.
• Historically, EBITDA has averaged -$4.8 million across 5 years, with a median of -$4.6 million in 2025.
• The widest YoY moves for EBITDA: up 74.03% in 2022, down 276.6% in 2022.
• Over 5 years, EBITDA stood at -$4.5 million in 2022, then tumbled by 51.89% to -$6.8 million in 2023, then increased by 8.66% to -$6.2 million in 2024, then advanced by 10.02% to -$5.6 million in 2025, then gained by 3.07% to -$5.4 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$5.4 million, -$5.6 million, and -$6.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.